Cabaletta Bio
CABA
CABA
63 hedge funds and large institutions have $135M invested in Cabaletta Bio in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $180M → $135M (-$44.6M)
29% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 17
78% less call options, than puts
Call options by funds: $118K | Put options by funds: $546K
Holders
63
Holding in Top 10
1
Calls
$118K
Puts
$546K
Top Buyers
| 1 | +$4.8M | |
| 2 | +$3.03M | |
| 3 | +$984K | |
| 4 |
Morgan Stanley
New York
|
+$736K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$591K |
Top Sellers
| 1 | -$6.29M | |
| 2 | -$2.52M | |
| 3 | -$1.64M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.56M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$898K |